Verified institutional research accounts only. Supplied for in vitro laboratory research and preclinical studies.
Peptides
Peptide YY (PYY) (3-36) (Human)
Catalog No. 059-02
Catalog #: 059-02
Size: 200 µg
Price: $104
Sequence: Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2 Molecular Weight: 4049.71 Purity: ≥ 96% Validation: Exhibits correct molecular weight Solubility: Soluble in water Storage: Up to 6 months in lyophilized form at 0-5°C. Appearance: White powder Contents: Each vial contains 200 µg of NET peptide.
Peptide YY(3-36)-induced inhibition of food intake in female monkeys. Papadimitriou MA, Krzemien AA, Hahn PM, Van vugt DA. Brain Res. 2007;1175:60-5.
PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity. Vrang N, Madsen AN, Tang-christensen M, Hansen G, Larsen PJ. Am J Physiol Regul Integr Comp Physiol. 2006;291(2):R367-75.
Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Neary NM, Small CJ, Druce MR, et al. Endocrinology. 2005;146(12):5120-7.
Peptide YY(3-36) inhibits morning, but not evening, food intake and decreases body weight in rhesus macaques. Koegler FH, Enriori PJ, Billes SK, et al. Diabetes. 2005;54(11):3198-204.
Peptide YY inhibits the growth of Barrett's esophageal adenocarcinoma in vitro. Mcfadden DW, Riggs DR, Jackson BJ, Vona-davis L. Am J Surg. 2004;188(5):516-9.
Institutional Access
Available only to verified institutional research accounts for in vitro laboratory research and preclinical studies.
Account Eligibility
